CRH's Acquisition Disclosure
Does anyone else find it odd that CRH does not disclose how much they paid for acquisitions in the press releases announcing them.......?
For example:
VANCOUVER, B.C. – September 11, 2017 – CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the “Company”), announces that it has completed an accretive transaction whereby CRH has acquired a 51% interest in a gastroenterology (“GI”) anesthesia practice in Central Colorado (“Central Colorado”). Central Colorado provides anesthesia services to three ambulatory surgical centers and is CRH’s second acquisition in Colorado. The transaction was financed through a combination of CRH’s credit facility and cash on hand.
Conversely, healthcare companies like Knight Therapeutics provide such information at the time of the announcement.
For example:
MONTREAL, Canada, January 26, 2017 – Knight Therapeutics Inc. (“Knight”) (TSX:GUD), a leading Canadian specialty pharmaceutical company, announced today that it has acquired 6,200,000 common shares (“Shares”) of Israeli based Protalix BioTherapeutics, Inc. (“Protalix”) at an average price of US$0.57 per share. Knight now owns approximately 5% of the outstanding common shares of Protalix. The Shares were purchased by Abir Therapeutics Ltd (“Abir”), Knight’s wholly-owned Israeli headquartered subsidiary, which owns 28.3% of Medison Pharma (“Medison”), Israel’s third largest pharmaceutical company ranked by revenues. It is anticipated that Medison will provide selected services to Abir in order to launch innovative pharmaceuticals in Israel.
If large companies like CIBC and Enbridge can provide information on the compensation they are paying for big acquisitions like PrivateBancorp and Spectra on the press release at the time they are announced (if not earlier), why can’t CRH do the same for their shareholders, and how is an investor / potential investor supposed to analyze an acquisition by CRH if they don’t know how much the company paid for it........?......It appears existing / potential shareholders don’t learn of the compensation paid until the following quarter's earnings report is released…..?.....Why the delay….?